Skip to content

Evaluating Structural and Functional Changes of Brain by fMRI and DTI in Patients With Intracranial Germ Cell Tumors

Evaluating Changes of Brain Networks and White Matter Fibers by fMRI and DTI After Treatments in Patients With Germ Cell Tumors in the Basal Ganglia

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03771625
Enrollment
30
Registered
2018-12-11
Start date
2019-06-01
Completion date
2021-11-01
Last updated
2019-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial Germ Cell Tumor

Keywords

fMRI, DTI, Intracranial Germ cell tumor, Basal ganglia

Brief summary

BOLD-fMRI and DTI scans are performed to patients with germ cell tumors in the basal ganglia before and after treatments. The changes of the MRI and muscle strength of patients during treatments are evaluated, and the association between these two are investigated.

Detailed description

Primary intracranial germ cell tumors are a specific entity of brain tumors with a variety of histological types and different degrees of malignancy. Intracranial GCTs make up 11.2% - 15.3% of primary intracranial tumors in Asian children compared with 3.6% in the US. And tumors located at the basal ganglia is much rarer. The investigators realize that most of patients with tumors at this location are involved with motor disfunction. And after treatments, some patients get relieved dramatically, but some others failed to get similar outcomes. To better understand the mechanism causing this difference of treatment outcomes, the investigators perform BOLD-fMRI and DTI scans to patients with germ cell tumors in the basal ganglia before and after treatments. The changes of the fMRI and muscle strength of patients during treatments are evaluated, and the association between these two are investigated.

Interventions

RADIATIONradiotherapy

whole brain with/without spinal cord

Sponsors

Beijing Neurosurgical Institute
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
3 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. age ≥3 years; 2. no history of brain radiotherapy; 3. no other known cause of movement and cognitive impairment; 4. no contraindications to the magnetic resonance imaging (MRI) scan;

Exclusion criteria

1. patients can not tolerate MR scan; 2. head motion is greater than 3 mm during functional MRI scanning.

Design outcomes

Primary

MeasureTime frameDescription
Changes of brain networks measured by BOLD-fMRI after treatments.The fMRI scans are performed: (1) before treatments in one week, (2) before radiotherapy in one week, (3) after radiotherapy in one week, (4) one year after radiotherapy.The brain networks during treatments are compared by functional connectivity.
Changes of white matter fibers measured by DTI after treatments.The DTI scans are performed along with the fMRI scans.The white matter fibers damaged by tumor are evaluated by FA and MD value.

Secondary

MeasureTime frameDescription
Changes of muscle strength after treatments.The muscle strength evaluation are performed at the same day before the fMRI scans.The limb muscle strength of patients are evaluated with the Medical Research Council (MRC) scale for muscle strength (grade 0-5).

Countries

China

Contacts

Primary ContactXiaoguang Qiu, M.D.
ttyy6611@sina.com010-67021832
Backup ContactShuai Liu, M.D.
liushuai9@foxmail.com010-67021832

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026